These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 8998788

  • 1. [Clinical use of potassium channel activators in angina pectoris: efficacy and tolerance].
    Specchia G, Marsico F, Micheletti T, Bona M.
    Cardiologia; 1995 Dec; 40(12 Suppl 1):91-5. PubMed ID: 8998788
    [No Abstract] [Full Text] [Related]

  • 2. Prescribing for angina.
    Shetty K.
    Practitioner; 1994 Jul; 238(1540):540-2. PubMed ID: 7937508
    [No Abstract] [Full Text] [Related]

  • 3. [Therapeutic application of myocardial cytoprotection].
    Ribeiro C.
    Rev Port Cardiol; 1994 Sep; 13(9):669-70. PubMed ID: 7818940
    [No Abstract] [Full Text] [Related]

  • 4. [Molsidomine and isosorbide dinitrate: a comparative trial of tolerance in long-term intake by IHD patients with stable angina of effort].
    Alimova EV, Martsevich SIu, Kutishenko NP, Metelitsa VI.
    Ter Arkh; 1997 Sep; 69(12):37-40. PubMed ID: 9503532
    [Abstract] [Full Text] [Related]

  • 5. Potassium channel activators in the management of ischaemic heart disease: a focus on nicorandil.
    Purcell H, Fox K.
    Br J Clin Pract; 1993 Sep; 47(3):150-4. PubMed ID: 8347442
    [Abstract] [Full Text] [Related]

  • 6. Nicorandil. A review of its pharmacology and therapeutic efficacy in angina pectoris.
    Frampton J, Buckley MM, Fitton A.
    Drugs; 1992 Oct; 44(4):625-55. PubMed ID: 1281076
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinical profile of nicorandil: an overview of its hemodynamic properties and therapeutic efficacy.
    Krumenacker M, Roland E.
    J Cardiovasc Pharmacol; 1992 Oct; 20 Suppl 3():S93-102. PubMed ID: 1282184
    [Abstract] [Full Text] [Related]

  • 10. [A new anti-ischemic drug for the treatment of stable effort angina pectoris: nicorandil. Comparison with placebo and isosorbide-5-mononitrate].
    Lai C, Onnis E, Solinas R, Orani E, Lai G, Cadeddu M, Cherchi A.
    Cardiologia; 1991 Sep; 36(9):703-11. PubMed ID: 1839369
    [Abstract] [Full Text] [Related]

  • 11. Antianginal and anti-ischemic efficacy of nicorandil in comparison with isosorbide-5-mononitrate and isosorbide dinitrate: results from two multicenter, double-blind, randomized studies with stable coronary heart disease patients.
    Döring G.
    J Cardiovasc Pharmacol; 1992 Sep; 20 Suppl 3():S74-81. PubMed ID: 1282180
    [Abstract] [Full Text] [Related]

  • 12. The effect of an angiotensin-converting enzyme inhibitor and a K+(ATP) channel opener on warm up angina.
    Edwards RJ, Redwood SR, Lambiase PD, Marber MS.
    Eur Heart J; 2005 Mar; 26(6):598-606. PubMed ID: 15618027
    [Abstract] [Full Text] [Related]

  • 13. Nitrate tolerance.
    Parker JO.
    Herz; 1984 Jun; 9(3):137-45. PubMed ID: 6430767
    [Abstract] [Full Text] [Related]

  • 14. Effects of nicorandil on rest and effort angina unresponsive to combination therapy with a calcium antagonist and oral nitrate.
    Araki H, Hayata N, Matsuguchi T, Nakamura M.
    Clin Ther; 1987 Jun; 9(2):174-82. PubMed ID: 2952276
    [Abstract] [Full Text] [Related]

  • 15. A potassium channel opener as monotherapy in chronic stable angina pectoris: comparison with placebo.
    Why HJ, Richardson PJ.
    Eur Heart J; 1993 Jul; 14 Suppl B():25-9. PubMed ID: 8370369
    [Abstract] [Full Text] [Related]

  • 16. Mechanisms of action of various ATP-sensitive potassium channel openers.
    Grover GJ.
    Cardiovasc Res; 1996 Jan; 31(1):177-9. PubMed ID: 8849605
    [No Abstract] [Full Text] [Related]

  • 17. [Potassium channel activators: hemodynamic effects at the systemic and coronary level].
    Perrone Filardi P, Chiariello M.
    Cardiologia; 1995 Dec; 40(12 Suppl 1):87-9. PubMed ID: 8998787
    [No Abstract] [Full Text] [Related]

  • 18. [Anti-angina activity of potassium-channel activators].
    Chiariello M, Duilio C, Ambrosio G.
    Cardiologia; 1993 Dec; 38(12 Suppl 1):459-63. PubMed ID: 8020048
    [Abstract] [Full Text] [Related]

  • 19. [The comparison of the efficacy of atenolol and isosorbide dinitrate therapy in chronic hypotension patients with stable angina pectoris].
    Idrisova EM, Borovkova NV, Stepacheva TA, Chernov VI, Karpov RS.
    Klin Med (Mosk); 2001 Dec; 79(1):37-40. PubMed ID: 11234265
    [Abstract] [Full Text] [Related]

  • 20. [Comparison of dinitrate isosorbide retard forms in ischemic heart disease patients with stable effort angina].
    Lupanov VP, Alekseeva IA, Vasil'eva NN, Komar OA, Romasiuk SS, Naumov VG.
    Ter Arkh; 2000 Dec; 72(9):33-6. PubMed ID: 11076413
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.